Clinical Trial Update: Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing ivermectin against a combination of hydroxychloroquine and antiretroviral drugs in asymptomatic SARS-CoV-2 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asymptomatic Infection

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• IVERMECTIN (Ivermectin)

Snippet

Sponsor: Mahidol University | Conditions: Asymptomatic Infections, SARS-CoV2 Infection | Phase 4 | Status: UNKNOWN